Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference20 articles.
1. Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis;Ingegnoli F;Best Pract Res Clin Rheumatol,2018
2. Systemic sclerosis;Allanore Y;Nat Rev Dis Primers,2015
3. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial;van den Hoogen FH;Br J Rheumatol,1996
4. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies;Elhai M;Rheumatology (Oxford),2012
5. Normotensive renal failure in systemic sclerosis;Helfrich DJ;Arthritis Rheum,1989
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting complement dysregulation: eculizumab in scleroderma renal crisis management—a case-based review;Rheumatology International;2024-08-15
2. Akutes Nierenversagen, Raynaud-Phänomen und thrombotische Mikroangiopathie – wie passt das zusammen?;Die Nephrologie;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3